These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data. Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104 [TBL] [Abstract][Full Text] [Related]
5. Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers. Miki T; Shimada H; Kim JS; Yamamoto Y; Sugino M; Kowa H; Heurling K; Zanette M; Sherwin PF; Senda M Ann Nucl Med; 2017 Apr; 31(3):260-272. PubMed ID: 28181118 [TBL] [Abstract][Full Text] [Related]
6. A Semiautomated Method for Quantification of F 18 Florbetapir PET Images. Joshi AD; Pontecorvo MJ; Lu M; Skovronsky DM; Mintun MA; Devous MD J Nucl Med; 2015 Nov; 56(11):1736-41. PubMed ID: 26338898 [TBL] [Abstract][Full Text] [Related]
7. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227. Kaneta T; Okamura N; Minoshima S; Furukawa K; Tashiro M; Furumoto S; Iwata R; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H Ann Nucl Med; 2011 Dec; 25(10):732-9. PubMed ID: 21792587 [TBL] [Abstract][Full Text] [Related]
8. Is there a difference in regional read [ Farrar G; Molinuevo JL; Zanette M Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1299-1308. PubMed ID: 30863934 [TBL] [Abstract][Full Text] [Related]
9. Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region. Chen K; Roontiva A; Thiyyagura P; Lee W; Liu X; Ayutyanont N; Protas H; Luo JL; Bauer R; Reschke C; Bandy D; Koeppe RA; Fleisher AS; Caselli RJ; Landau S; Jagust WJ; Weiner MW; Reiman EM; J Nucl Med; 2015 Apr; 56(4):560-6. PubMed ID: 25745091 [TBL] [Abstract][Full Text] [Related]
10. A deep learning model for generating [ Sanaat A; Boccalini C; Mathoux G; Perani D; Frisoni GB; Haller S; Montandon ML; Rodriguez C; Giannakopoulos P; Garibotto V; Zaidi H Eur J Nucl Med Mol Imaging; 2024 Oct; 51(12):3518-3531. PubMed ID: 38861183 [TBL] [Abstract][Full Text] [Related]
11. Pitfalls of voxel-based amyloid PET analyses for diagnosis of Alzheimer's disease: artifacts due to non-specific uptake in the white matter and the skull. Arai A; Kaneta T; Okamura N; Tashiro M; Iwata R; Takanami K; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H Tohoku J Exp Med; 2014 Nov; 234(3):175-81. PubMed ID: 25311079 [TBL] [Abstract][Full Text] [Related]
12. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects. Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770 [TBL] [Abstract][Full Text] [Related]
13. Temporal and anatomical distribution of Yun T; Lee W; Kang JH; Yang MP; Kang BT BMC Vet Res; 2020 Jan; 16(1):17. PubMed ID: 31952531 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease. Rodriguez-Vieitez E; Carter SF; Chiotis K; Saint-Aubert L; Leuzy A; Schöll M; Almkvist O; Wall A; Långström B; Nordberg A J Nucl Med; 2016 Jul; 57(7):1071-7. PubMed ID: 26912447 [TBL] [Abstract][Full Text] [Related]
15. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [ Bucci M; Savitcheva I; Farrar G; Salvadó G; Collij L; Doré V; Gispert JD; Gunn R; Hanseeuw B; Hansson O; Shekari M; Lhommel R; Molinuevo JL; Rowe C; Sur C; Whittington A; Buckley C; Nordberg A Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2183-2199. PubMed ID: 33844055 [TBL] [Abstract][Full Text] [Related]
16. Automated PET-only quantification of amyloid deposition with adaptive template and empirically pre-defined ROI. Akamatsu G; Ikari Y; Ohnishi A; Nishida H; Aita K; Sasaki M; Yamamoto Y; Sasaki M; Senda M Phys Med Biol; 2016 Aug; 61(15):5768-80. PubMed ID: 27405579 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of early-phase [ Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429 [TBL] [Abstract][Full Text] [Related]
18. Assessing Amyloid Pathology in Cognitively Normal Subjects Using Collij LE; Konijnenberg E; Reimand J; Kate MT; Braber AD; Lopes Alves I; Zwan M; Yaqub M; van Assema DME; Wink AM; Lammertsma AA; Scheltens P; Visser PJ; Barkhof F; van Berckel BNM J Nucl Med; 2019 Apr; 60(4):541-547. PubMed ID: 30315145 [TBL] [Abstract][Full Text] [Related]